KA/EN
Register
Medicines reference
Search
Search
Product

Feligen CRP

Favourites

Feline calicivirus + Feline herpesvirus + Feline parvovirus · Virbac S.A.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Cat Cat 1 ml
Reconstitute and inject one 1 ml dose subcutaneously from 8 weeks; repeat after 3-4 weeks. A third dose from 15 weeks may be appropriate when maternal antibodies are expected. Revaccinate annually. Vaccinate healthy cats only; deworming at least 10 days beforehand is recommended. Do not use during pregnancy or lactation. Digestive signs, oedema, fever or lethargy can occur; allergy/anaphylaxis is very rare.
 · two-dose primary series, then annual revaccination		 two-dose primary series, then annual revaccination Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფელიგენი CRP
№ 210-11; 256-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Feligen CRP, Suspension

lyophilisate and solvent for injection, 1 ml dose for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.3/10
Very good
vetman assessment

Feligen CRP

lyophilisate and solvent for injection, 1 ml dose for cats
Assessed clinical scopeCat · Full cat label: active immunisation against feline panleucopenia, calicivirus and herpesvirus, with the labelled primary course and annual revaccination · Subcutaneous
Care settingPreventive feline vaccination with examination, cold-chain control, injection-site planning and emergency treatment available
vetman score 8.3/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 210-11; 256-11 · Verified on 21 Oct 2026

A well-documented feline core vaccine with strong panleucopenia value and useful respiratory-disease reduction. Its annual schedule, maternal-antibody planning and non-sterilising FCV/FHV protection are the main limitations.

Regulatory and scientific credibility9.0/10

The exact 1 ml presentation is registered in Georgia and supported by a current regulator SPC defining strains, potency, schedule, restrictions and adverse reactions.

Clinical efficacy8.1/10

All three antigens are global feline core targets. Panleucopenia protection is strong, while FCV and FHV vaccination mainly reduces disease rather than reliably preventing every infection or shedding episode; maternal antibody can require a final kitten dose at 16 weeks or later.

Safety and tolerability8.0/10

The live attenuated vaccine has a favourable profile in healthy cats, but transient systemic or local reactions and very rare allergy or anaphylaxis remain relevant; pregnancy and lactation use is not recommended by the label.

Clinical practicality7.8/10

The fixed 1 ml SC dose is straightforward, but reconstitution, cold-chain control, a two-dose primary series, possible third kitten dose and annual revaccination create recurring work.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate healthy cats only; do not use in hypersensitivity to a component.
  • Do not use during pregnancy or lactation.
  • Maternal antibodies may require a third dose from 15 weeks and a final core dose at 16 weeks or later.
  • FCV and FHV vaccination reduces disease but does not reliably prevent every infection, carrier state or shedding episode.
  • Very rare allergy or anaphylaxis requires immediate treatment; monitor transient fever, lethargy, digestive signs and oedema.
  • Do not mix or co-administer another veterinary medicine unless exact compatibility is established.
  • Maintain the cold chain, reconstitute aseptically with the supplied solvent and use the full 1 ml dose promptly.
Assessment sources
  1. EU UPD SPC 20262026
  2. WSAVA vaccination 20242024
  3. AAHA/AAFP feline vaccination 20202020
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Feline calicivirus4.6 log10 CCID50/dose Feline herpesvirus5 log10 CCID50/dose Feline parvovirus3.7 log10 CCID50/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Virbac S.A. · France
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფელიგენი CRP
№ 210-11; 256-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
Reconstitute and inject one 1 ml dose subcutaneously from 8 weeks; repeat after 3-4 weeks. A third dose from 15 weeks may be appropriate when maternal antibodies are expected. Revaccinate annually. Vaccinate healthy cats only; deworming at least 10 days beforehand is recommended. Do not use during pregnancy or lactation. Digestive signs, oedema, fever or lethargy can occur; allergy/anaphylaxis is very rare.
 Cat Any weight Subcutaneous two-dose primary series, then annual revaccination
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Feligen CRP - official product information
EU Union Product Database, 2026

Feline calicivirus: No dose supported by a publicly verifiable source yet

Feline herpesvirus: No dose supported by a publicly verifiable source yet

Feline parvovirus: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗